Correlation Between Vigil Neuroscience and Acumen Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Vigil Neuroscience and Acumen Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vigil Neuroscience and Acumen Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vigil Neuroscience and Acumen Pharmaceuticals, you can compare the effects of market volatilities on Vigil Neuroscience and Acumen Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vigil Neuroscience with a short position of Acumen Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vigil Neuroscience and Acumen Pharmaceuticals.

Diversification Opportunities for Vigil Neuroscience and Acumen Pharmaceuticals

0.31

Correlation Coefficient

Vigil Neuroscience  Acumen Pharmaceuticals

Weak diversification

The 3 months correlation between Vigil and Acumen is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Vigil Neuroscience and Acumen Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acumen Pharmaceuticals and Vigil Neuroscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vigil Neuroscience are associated (or correlated) with Acumen Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acumen Pharmaceuticals has no effect on the direction of Vigil Neuroscience i.e., Vigil Neuroscience and Acumen Pharmaceuticals go up and down completely randomly.

Pair Corralation between Vigil Neuroscience and Acumen Pharmaceuticals

Given the investment horizon of 90 days Vigil Neuroscience is expected to generate 0.92 times more return on investment than Acumen Pharmaceuticals. However, Vigil Neuroscience is 1.08 times less risky than Acumen Pharmaceuticals. It trades about -0.07 of its potential returns per unit of risk. Acumen Pharmaceuticals is currently generating about -0.15 per unit of risk. If you would invest  351.00  in Vigil Neuroscience on June 24, 2024 and sell it today you would lose (25.00) from holding Vigil Neuroscience or give up 7.12% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Vigil Neuroscience  vs.  Acumen Pharmaceuticals

Vigil Neuroscience

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vigil Neuroscience has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's technical and fundamental indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Acumen Pharmaceuticals

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Acumen Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Acumen Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Vigil Neuroscience and Acumen Pharmaceuticals

The main advantage of trading using opposite Vigil Neuroscience and Acumen Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vigil Neuroscience position performs unexpectedly, Acumen Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will offset losses from the drop in Acumen Pharmaceuticals' long position.

The idea behind Vigil Neuroscience and Acumen Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.